Group Post |
White House faces April 18 deadline on transit mask mandate |
FNUOvviyaa |
Group Post |
In Some States, Monkeypox Is Infecting Many More Black Americans |
FNUOvviyaa |
Group Post |
Factbox: Monkeypox cases around the world |
FNUOvviyaa |
Group Post |
‘Tripledemic:’ What Happens When Flu, RSV, and COVID-19 Cases Collide? |
FNUOvviyaa |
Group Post |
Scientists are narrowing in on why some people keep avoiding Covid. BA.5 could end that luck. |
FNUOvviyaa |
Group Post |
COVID-19 rising in Americas, biggest spike in South America- PAHO |
FNUOvviyaa |
Group Post |
COVID endangers fragile health systems in Pacific nations |
FNUOvviyaa |
Group Post |
Biden's Operation Warp Speed revival stumbles out of the gate |
FNUOvviyaa |
Group Post |
UNICEF sounds alarm over fast-spreading cholera outbreaks in Africa |
FNUOvviyaa |
Group Post |
As post-Thanksgiving COVID hospitalizations spike, Dr. Jha urges people to get new booster |
FNUOvviyaa |
Group Post |
Novavax’s Covid-19 vaccine wins backing of CDC advisory panel |
FNUOvviyaa |
Group Post |
The ‘five pandemics’ driving 1 million U.S. Covid deaths |
FNUOvviyaa |
Group Post |
Biden names U.S. monkeypox coordinators as more states cite emergencies |
FNUOvviyaa |
Group Post |
FDA authorizes first Covid-19 breath test |
FNUOvviyaa |
Group Post |
Integrating Primary Care and Public Health to Save Lives: Lessons from COVID-19 |
FNUOvviyaa |
Group Post |
State to report COVID-19 data once per week as cases decline |
FNUOvviyaa |
Group Post |
What is monkeypox, and how can you stay safe as it spreads? |
FNUOvviyaa |
Group Post |
Uganda takes the lead: piloting the Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research |
FNUOvviyaa |
Group Post |
Pfizer's Paxlovid reduces COVID risk in seniors regardless of vaccine status -study |
FNUOvviyaa |
Group Post |
COVID pressures China's hospitals as countries mandate tests for travelers |
FNUOvviyaa |
Group Post |
Addressing myths about monkeypox: A look at symptoms, treatment and other common questions |
FNUOvviyaa |
Group Post |
BA.4 and BA.5 Omicron: How worried should we be? |
FNUOvviyaa |
Group Post |
Floods, heat and other climate hazards are turning 218 infectious diseases into bigger threats, study says |
FNUOvviyaa |
Group Post |
BA.5 spurs new calls to fund next-generation COVID-19 vaccines |
FNUOvviyaa |
Group Post |
Health Care — Pfizer to expand domestic manufacturing of Paxlovid |
FNUOvviyaa |
Recent Comments